Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2015 (2015), Article ID 325305, 5 pages
http://dx.doi.org/10.1155/2015/325305
Clinical Study

Analysis of Japanese Patients Treated with or without Long-Term Epirubicin Plus Ara-C Intravesical Instillation Therapy for Low-Grade Superficial Bladder Cancer

1Department of Urology, Social Insurance Funabashi Central Hospital, 6-13-10 Kaijin, Funabashi, Chiba 273-8556, Japan
2Department of Urology, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama 930-0194, Japan
3Department of Pathology, Social Insurance Funabashi Central Hospital, 6-13-10 Kaijin, Funabashi, Chiba 273-8556, Japan
4Department of Pathology, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan

Received 26 September 2014; Revised 31 March 2015; Accepted 31 March 2015

Academic Editor: Ronald M. Bukowski

Copyright © 2015 Tomonori Kato et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [2 citations]

The following is the list of published articles that have cited the current article.

  • Yasuyoshi Miyata, and Hideki Sakai, “Predictive Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer Treated with Intravesical Therapy,” Disease Markers, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Ching-Wen Liu, Yu-Tse Wu, Kai-Jen Lin, Tsan-Jung Yu, Yu-Liang Kuo, and Li-Ching Chang, “A Hydrogel-Based Epirubicin Delivery System for Intravesical Chemotherapy,” Molecules, vol. 21, no. 6, pp. 712, 2016. View at Publisher · View at Google Scholar